BioCentury This Week
BioCentury
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Episodes
Mentioned books
Jul 29, 2021 • 17min
Ep. 70 - Prepping for China’s IP law with Jones Day’s Tony Chen
Reach us by sending a text
Jul 27, 2021 • 15min
Ep. 69 - Allaying Aduhelm Concerns, Plus Master Protocols, Arvinas-Pfizer
Reach us by sending a text
Jul 20, 2021 • 26min
Ep. 68 - Drug Pricing Pressure, Plus European Deal Trends
Reach us by sending a text
Jul 13, 2021 • 32min
Ep. 67 - Aduhelm: a Tangled Plot; Plus, INTREPID Pandemic Planning
Reach us by sending a text
Jul 6, 2021 • 22min
Ep. 66 - Biotechs hit 3Q with Coolers Full of Cash; plus Distillery on Tap
Reach us by sending a text
Jun 29, 2021 • 23min
Ep. 65 - Optimism for Intellia's CRISPR Breakthrough, Concerns about Aduhelm
Reach us by sending a text
Jun 24, 2021 • 19min
Ep. 64 - Amyloid Analysis: Stress Testing FDA's Logic on Surrogate Endpoint
Reach us by sending a text
Jun 21, 2021 • 25min
Ep. 63 - Woodcock, Noubar and Genmab’s dealmaking: A BioCentury Podcast
Reach us by sending a text
Jun 14, 2021 • 19min
Ep. 62 - Reflecting on the Implications of Aduhelm's Approval: A BioCentury Podcast
Reach us by sending a text
Jun 8, 2021 • 25min
Ep. 61 - Dissecting FDA's Aducanumab Decision
Reach us by sending a text
